|
ZNF45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.839000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.750000E-01 |
| Normal-vs-Stage2 |
5.091900E-02 |
| Normal-vs-Stage3 |
1.19870000003797E-06 |
| Normal-vs-Stage4 |
2.9108000000333E-06 |
| Stage1-vs-Stage2 |
6.605600E-02 |
| Stage1-vs-Stage3 |
7.02789999973419E-07 |
| Stage1-vs-Stage4 |
1.86642999999709E-05 |
| Stage2-vs-Stage3 |
1.436780E-01 |
| Stage2-vs-Stage4 |
1.009180E-01 |
| Stage3-vs-Stage4 |
6.658800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.457300E-03 |
| Normal-vs-AfricanAmerican |
2.527500E-02 |
| Normal-vs-Asian |
9.689600E-01 |
| Caucasian-vs-AfricanAmerican |
5.148200E-01 |
| Caucasian-vs-Asian |
4.410800E-01 |
| AfricanAmerican-vs-Asian |
3.449600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.182160E-03 |
| Normal-vs-Female |
7.587700E-02 |
| Male-vs-Female |
1.963600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.734600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.918400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.540500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.131820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.143400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.505400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.172800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.529800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.320100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.673440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.197700E-02 |
| Normal-vs-Grade 2 |
9.325400E-01 |
| Normal-vs-Grade 3 |
2.14579999999742E-05 |
| Normal-vs-Grade 4 |
9.15910003396192E-09 |
| Grade 1-vs-Grade 2 |
1.333840E-01 |
| Grade 1-vs-Grade 3 |
5.963800E-04 |
| Grade 1-vs-Grade 4 |
3.76449999994755E-06 |
| Grade 2-vs-Grade 3 |
2.47870000003036E-06 |
| Grade 2-vs-Grade 4 |
1.45609999613328E-08 |
| Grade 3-vs-Grade 4 |
6.983700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.614200E-01 |
| Normal-vs-ccB subtype |
9.90890000052147E-07 |
| ccA subtype-vs-ccB subtype |
8.16649969870298E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.223800E-03 |
| Normal-vs-N1 |
3.718000E-02 |
| N0-vs-N1 |
1.865800E-01 |
|
|
